SightfileU.S. market data from official filings

EQUILLIUM INC (EQ)

Name: EQUILLIUM INC (EQ) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001746466 · EDGAR filings · Updated 2026-06-05

EQUILLIUM INC (EQ) has reported institutional ownership of 64.1%, with 50 institutional managers holding positions valued at $81.0M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership

64.1%

Institutional managers

Reported 13F value

$81.0M

Insider activity

21 trans.

−$1.53M net selling

Data flags

2 active

from SEC filings

Latest updates

2026-06-05 — Notice of proposed sale filed (Form 144)
2026-06-05 — Insider transaction reported (Form 4)
2026-06-05 — Insider transaction reported (Form 4)
2026-06-04 — Notice of proposed sale filed (Form 144)
2026-05-29 — Insider transaction reported (Form 4)
2026-05-29 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, EQUILLIUM INC has 50 institutional holders and institutional ownership of 64.1%.

Insider activity

Insiders reported 21 transactions (0 buys, 12 sells) across 2 reporting insiders, with a net reported value of −$1.53M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-03-25 (recurring since 2025-03-27) — source filing. The authoritative details are those stated in the filing itself.

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2025-06-13 (recurring since 2023-04-06) — source filing. The authoritative details are those stated in the filing itself.

Related companies

TILRAY BRANDS INC (TLRY) · SIGHT SCIENCES INC (SGHT) · TRISALUS LIFE SCIENCES (TLSI) · GOSSAMER BIO INC (GOSS) · ADLAI NORTYE LTD (ANL) · DIAMEDICA THERAPEUTICS INC (DMAC)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-05.